• Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

What Women Don't Know about their Health is Dangerous


Poll: 91% of women don’t know heart disease is the #1 cause of death in women and 81% aren’t aware that the Pap test screens only for cervical cancer. Counseling and education are needed.

Gaps in women's knowledge about their own health and their concerns about not "being heard" by their primary care clinicians are among the troubling findings of a new poll conducted by primary care collaborative MDVIP and Ipsos.

In addition to having limited knowledge about the health issues that most affect them, significant portions of those surveyed said they don't talk to their primary care clinician about mental health, including feelings of depression and anxiety; 1 in 3 say some of their concerns haven't been taken seriously and that they felt there wasn't time enough to ask all their questions.

The short slide show below is a top-line look at the findings and may be interesting, even surprising, to primary care clinicians.

The Ipsos poll was conducted between March 5 and 9, 2021, on behalf of MDVIP. A sample of 1446 women aged ≥20 years from the continental US, Alaska, and Hawaii were interviewed online in English.

Related Videos
New Research Amplifies Impact of Social Determinants of Health on Cardiometabolic Measures Over Time
Where Should SGLT-2 Inhibitor Therapy Begin? Thoughts from Drs Mikhail Kosiborod and Neil Skolnik
Related Content
© 2024 MJH Life Sciences

All rights reserved.